chr14-53949882-CCTTTT-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_001202.6(BMP4):c.*145_*149del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000745 in 590,332 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000011 ( 0 hom., cov: 0)
Exomes 𝑓: 0.000087 ( 0 hom. )
Consequence
BMP4
NM_001202.6 3_prime_UTR
NM_001202.6 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.425
Genes affected
BMP4 (HGNC:1071): (bone morphogenetic protein 4) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein regulates heart development and adipogenesis. Mutations in this gene are associated with orofacial cleft and microphthalmia in human patients. The encoded protein may also be involved in the pathology of multiple cardiovascular diseases and human cancers. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population sas. gnomad4_exome allele frequency = 0.0000866 (43/496640) while in subpopulation SAS AF= 0.00117 (40/34302). AF 95% confidence interval is 0.000879. There are 0 homozygotes in gnomad4_exome. There are 34 alleles in male gnomad4_exome subpopulation. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAdExome4 at 43 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BMP4 | NM_001202.6 | c.*145_*149del | 3_prime_UTR_variant | 4/4 | ENST00000245451.9 | NP_001193.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BMP4 | ENST00000245451.9 | c.*145_*149del | 3_prime_UTR_variant | 4/4 | 1 | NM_001202.6 | ENSP00000245451 | P1 | ||
BMP4 | ENST00000558984.1 | c.*145_*149del | 3_prime_UTR_variant | 3/3 | 1 | ENSP00000454134 | P1 | |||
BMP4 | ENST00000559087.5 | c.*145_*149del | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000453485 | P1 | |||
BMP4 | ENST00000417573.5 | c.*145_*149del | 3_prime_UTR_variant | 4/4 | 5 | ENSP00000394165 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000107 AC: 1AN: 93692Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
1
AN:
93692
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000866 AC: 43AN: 496640Hom.: 0 AF XY: 0.000134 AC XY: 34AN XY: 253124
GnomAD4 exome
AF:
AC:
43
AN:
496640
Hom.:
AF XY:
AC XY:
34
AN XY:
253124
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000107 AC: 1AN: 93692Hom.: 0 Cov.: 0 AF XY: 0.0000223 AC XY: 1AN XY: 44862
GnomAD4 genome
AF:
AC:
1
AN:
93692
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
44862
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Cleft Lip +/- Cleft Palate, Autosomal Dominant Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Syndromic Microphthalmia, Dominant Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Orofacial cleft Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
BMP4-Related Syndromic Microphthalmia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at